Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

OptimizeRx Corporation - Common Stock (NQ:OPRX)

8.250 -0.980 (-10.62%)
Streaming Delayed Price Updated: 12:15 PM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about OptimizeRx Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
Market Embraces Disruptive AI-Powered Capabilities 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
7 Top Undervalued Stocks Primed for a Multibagger Recovery ↗
These seven undervalued stocks are trading at discounted prices but have the potential to deliver multibagger returns in the coming years. 
Via InvestorPlace
News headline image
Where OptimizeRx Stands With Analysts ↗
 
Via Benzinga
News headline image
OPRX Stock Earnings: OptimizeRx Beats Revenue for Q4 2023 ↗
OPRX stock results show that OptimizeRx beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
OptimizeRx Earnings Preview ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 6, 2023 ↗
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
Via Benzinga
News headline image
Earnings Scheduled For March 28, 2024 ↗
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. 
Via Benzinga
News headline image
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
A Preview Of OptimizeRx's Earnings ↗
 
Via Benzinga
News headline image
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
Empowering healthcare providers to remove barriers to care 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
OptimizeRx Reports Third Quarter 2023 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET
Executive Leadership expands with Steve Silvestro being promoted to President, and Theresa Greco assuming the role of Chief Commercial Officer 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
Digital Health Tech OptimizeRx's Acquisition of Medicx Health To Boost Earnings And Market Potential: Analyst ↗
OptimizeRx Corp (NASDAQ: OPRX) agreed to acquire Scottsdale, Arizona-based Healthy Offers Inc, dba Medicx Health,  
Via Benzinga
News headline image
Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform
The New AI-Directed Capability Unites Point-of-Care and Traditional Digital Medias to Provide a Comprehensive Solution for Pharmaceutical Marketing 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Expands AI Powered Omnichannel Platform
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) jumped 85.4% to $0.1267 after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project. 
Via Benzinga
News headline image
Stocks Lower As Fitch Warning Weighs On Bank Sector ↗
Via Talk Markets
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Delcath Systems Shares Are Trading Higher By Around 58%; Here Are 20 Stocks Moving Premarket ↗
Gainers Delcath Systems, Inc. (NASDAQ: DCTH) shares surged 57.7% to $4.93 in pre-market trading after the company reported the FDA approval of HEPZATO KIT™ for the treatment of adult patients with... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Pre-market stock movers are a hot topic with investors this morning and we're checking out the biggest ones worth watching on Tuesday! 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.